{
  "meta": {
    "title": "Concepts_And_Classifications_Vaccines_And_Cold_Chain",
    "url": "https://brainandscalpel.vercel.app/concepts-and-classifications-vaccines-and-cold-chain-563756d6.html",
    "scrapedAt": "2025-11-29T18:35:44.178Z"
  },
  "questions": [
    {
      "id": 6301,
      "choices": [
        {
          "id": 25173,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgG</span></span></p>"
        },
        {
          "id": 25174,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgM</span></span></p>"
        },
        {
          "id": 25175,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgA</span></span></p>"
        },
        {
          "id": 25176,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IgD</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 28-year-old man, planning an adventurous journey to a region known for exotic infectious diseases, consults a travel clinic for necessary immunizations. During his visit, he receives a vaccine to protect against a specific pathogen prevalent in his travel destination. In the context of his body&#39;s immune response to this vaccine, which type of antibody will his immune system predominantly produce first? This initial antibody plays a pivotal role in the primary immune response, acting as the first line of defense against new pathogens.</span></span></p>",
      "unique_key": "Q2677527",
      "question_audio": null,
      "question_video": null,
      "map_id": 34089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. IgM</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The<strong> antibody</strong> that is <strong>elicited first</strong> is the entire <strong>IgM</strong> type. The <strong>IgM antibody titer rises</strong> steadily during the <strong>next 2-3 days</strong> or more, reaches a <strong>peak level</strong>, and then <strong>declines</strong> almost <strong>as fast as</strong> it <strong>developed</strong>. Meanwhile, if the <strong>antigenic</strong> stimulus was sufficient,<strong> IgG antibody</strong> would appear in a <strong>few days.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Types of immunoglobulins -&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>IgG:</strong> Comprises<strong> 85%</strong> of <strong>total serum immunoglobulins,</strong> largely <strong>extravascular</strong>, the only class of immunoglobulins to<strong> cross the placenta.</strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>IgM:</strong> Comprises <strong>10% of total serum immunoglobulins</strong>, indicative of <strong>recent infection,</strong> has <strong>high agglutinating</strong> and <strong>complement-fixating</strong> ability.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>IgA:</strong> Comprises <strong>15% of total serum immunoglobulins,</strong> predominantly <strong>found</strong> in <strong>secretions,</strong> primary<strong> defence</strong> mechanism at <strong>mucous membranes</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>IgD:</strong> Exact function<strong> not known</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>IgE</strong>: Concentrated in<strong> submucous tissues</strong>, responsible for <strong>immediate allergic anaphylaxis reaction.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Identify IgM</strong> as the<strong> first</strong> type of <strong>antibody</strong> produced in the <strong>primary immune response</strong> following initial <strong>vaccination or antigen exposure</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26th ed pg 109.</strong></span></span></p>",
      "correct_choice_id": 25174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6306,
      "choices": [
        {
          "id": 25193,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Subclinical infection</span></span></p>"
        },
        {
          "id": 25194,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immunization of herd</span></span></p>"
        },
        {
          "id": 25195,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Herd structure</span></span></p>"
        },
        {
          "id": 25196,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immunity through maternal antibodies&nbsp;</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a workshop on public health, a medical officer emphasizes the importance of herd immunity in preventing outbreaks. Later, during a breakout session, participants brainstorm on factors that influence herd immunity. Which of the following factors raised by a participant does NOT play a significant role in establishing or maintaining herd immunity?</span></span></p>",
      "unique_key": "Q3260424",
      "question_audio": null,
      "question_video": null,
      "map_id": 34082,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. &nbsp;Immunity through maternal antibodies&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Short-lived passive immunity</strong> obtained through <strong>maternal antibodies</strong>, it can <strong>protect infants</strong> for a <strong>short period</strong>, and they wane over time and <strong>do not</strong> provide <strong>lasting community-wide protection</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd Immunity:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd immunity</strong> is also called as <strong>Population Immunity</strong>. It is the <strong>indirect protection</strong> from an <strong>infectious disease</strong> that happens when a population is <strong>immune</strong> either through <strong>vaccination</strong> or <strong>immunity</strong> developed through <strong>previous infection.</strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd Immunity</strong> is the level of <strong>resistance</strong> of a community or group of people to a<strong> particular disease.</strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is <strong>neither possible nor necessary</strong> to achieve <strong>100% herd immunity</strong>&nbsp;to <strong>control a disease</strong>.&nbsp;</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Herd immunity may be <strong>determined</strong> <strong>by Serological Surveys.</strong>&nbsp;</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Herd immunity describes a <strong>type of immunity</strong> that occurs when the <strong>vaccination</strong> of a portion of the <strong>population (or herd)</strong> provides <strong>protection</strong> to <strong>un-vaccinated individuals</strong>.</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Herd immunity <strong>does not</strong> <strong>protect</strong> the individual in the case of <strong>tetanus.</strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd Immunity Threshhold</strong>: <strong>Virologists</strong> have found that when a certain percentage of a <strong>population</strong> is <strong>vaccinated</strong>, the<strong> spread</strong> of the <strong>disease</strong> is <strong>effectively stopped</strong>; this&nbsp;critical percentage (HIT) <strong>depends</strong> on the <strong>disease and the vaccine.</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Elements that contribute to herd immunity are: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> Occurrence of <strong>clinical and subclinical infection</strong> in the herd.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Immunization</strong> of the herd.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Herd structure</strong>&nbsp;(hosts, alternative animal hosts, insect vectors, environmental &amp; social factors).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd immunity</strong> is the <strong>indirect</strong> <strong>protection</strong> from an <strong>infectious disease</strong> that happens when a <strong>population</strong> is <strong>immune</strong> either through <strong>vaccination or immunity</strong> developed through <strong>previous infection</strong>.&nbsp;It is <strong>neither</strong> possible <strong>nor</strong> necessary to<strong> achieve</strong> <strong>100% herd immunity</strong>&nbsp;to <strong>control</strong> a <strong>disease</strong>.&nbsp;Herd immunity may be <strong>determined</strong> by <strong>Serological Surveys</strong>.&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 26<sup>th</sup> ed pg 110.</strong></span></span></p>",
      "correct_choice_id": 25196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6312,
      "choices": [
        {
          "id": 25217,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Recent initiation of chemotherapy for breast cancer</span></span></p>"
        },
        {
          "id": 25218,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Systemic lupus erythematosus (SLE) under immunosuppressive therapy</span></span></p>"
        },
        {
          "id": 25219,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Asymptomatic HIV Infection&nbsp;</span></span></p>"
        },
        {
          "id": 25220,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Current pregnancy</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 39-year-old woman visits your clinic for pre-travel health advice. She is planning a humanitarian mission to a rural area in Africa and is seeking guidance on necessary immunizations. During the consultation, you evaluate her health history and current medical status to determine the suitability of live vaccines for her. Given her specific health profile, you need to identify which aspect of her medical history does NOT constitute a contraindication to receiving live vaccines. This particular attribute, despite being a part of her health background, does not automatically disqualify her from receiving live vaccines.</span></span></p>",
      "unique_key": "Q1456743",
      "question_audio": null,
      "question_video": null,
      "map_id": 34084,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. &nbsp;Asymptomatic HIV infection</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Vaccines contraindicated in HIV:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Asymptomatic HIV: NONE</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Symptomatic HIV: All live vaccines<strong> EXCEPT MMR, Varicella &amp; Zoster</strong> may be given if required</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>CONTRAINDICATIONS OF LIVE VACCINES </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immunodeficient individuals (<strong>Symptomatic HIV infection</strong>) <strong>except BCG vaccine</strong> </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Immunosuppressed individuals</strong> (patient with <strong>leukaemia </strong>or patients on <strong>antimetabolites, steroids, or radiation</strong>) </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Pregnancy</strong> (<strong>except yellow fever</strong>)</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Recent initiation of chemotherapy for breast cancer: &nbsp;Immunosuppression</strong> is the <strong>contraindication</strong> for <strong>live vaccine</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Systemic lupus erythematosus (SLE) under immunosuppressive therapy: </strong>&nbsp;Patients on immunosuppressive therapy, such as those with SLE, are generally <strong>advised</strong> against <strong>live vaccines</strong> due to the <strong>heightened risk</strong> of <strong>vaccine-induced disease</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Current pregnancy: </strong>&nbsp;<strong>All live vaccines</strong> are <strong>contraindicated</strong> in <strong>Pregnancy</strong> <strong>EXCEPT Yellow fever vaccine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Some important pointers related to <strong>Vaccine Contraindication</strong>s -&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated in <strong>Pregnancy</strong>: All live vaccines <strong>EXCEPT Yellow fever vaccine</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated in <strong>Immuno-suppression</strong>: <strong>All live vaccines</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated <strong>in Corticosteroid therapy</strong>: <strong>All live vaccines</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated in <strong>fever</strong>: <strong>Typhoid vaccines</strong> (Typhoral;&nbsp;Typhim &ndash; Vi;&nbsp;TAB)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated <strong>in ARTI/diarrhoea</strong>: <strong>NONE</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines <strong>contraindicated together</strong>: <strong>Yellow fever and Cholera vaccine</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccine contraindicated in <strong>Preterm-premature baby</strong> <strong>with birth weight &lt; 2 kg</strong>: <strong>Hepatitis B</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated in <strong>age &lt; 1 year (infants):</strong> <strong>Yellow fever vaccine;&nbsp;Meningococcal vaccine and&nbsp;Pneumococcal vaccine</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines contraindicated in <strong>age &lt; 2 years</strong>:&nbsp;<strong>Meningococcal vaccine;&nbsp;Pneumococcal vaccine and&nbsp;Typhoid vaccines</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccine contraindicated in <strong>progressive neurological disease</strong>: <strong>Pertussis vaccine</strong> (Pertussis vaccine is not contraindicated in epilepsy controlled on medications, Cerebral palsy).</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Only <strong>absolute contraindication to killed vaccines</strong>: <strong>Severe</strong> local or <strong>general reaction</strong> to a <strong>previous dose.</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Live vaccines</strong> should <strong>not</strong> be administered to persons with <strong>immune deficiency diseases</strong> or to persons whose <strong>immune response</strong> may be <strong>suppressed</strong> because of <strong>leukaemia, lymphoma</strong> or <strong>malignancy</strong> or because of therapy with <strong>corticosteroids, alkylating agents, antimetabolic agents, or radiation, Pregnancy.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 26<sup>th</sup> ed pg 111.&nbsp;</strong></span></span></p>",
      "correct_choice_id": 25219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6307,
      "choices": [
        {
          "id": 25197,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diphtheria&nbsp;</span></span></p>"
        },
        {
          "id": 25198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Poliomyelitis</span></span></p>"
        },
        {
          "id": 25199,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tetanus</span></span></p>"
        },
        {
          "id": 25200,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Measles</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A public health official is addressing a group of healthcare professionals about the critical role of vaccinations in controlling infectious diseases. The official emphasizes the concept of herd immunity, which occurs when a significant portion of a community is vaccinated, thereby providing indirect protection to those who are not vaccinated. This phenomenon can effectively prevent the spread of certain infectious diseases. However, not all diseases can be controlled through herd immunity. The official poses a question to the audience: Among following diseases, which one does NOT benefit from herd immunity?</span></span></p>",
      "unique_key": "Q9176604",
      "question_audio": null,
      "question_video": null,
      "map_id": 34083,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Tetanus</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Tetanus</strong> does <strong>not</strong> <strong>pass</strong> from <strong>person to person</strong>, that&#39;s why there is <strong>no herd immunity</strong> seen with it.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options: </strong>In the cases of<strong> Diphtheria (Option A), Poliomyelitis (Option B), and Measles (Option D</strong>),&nbsp;the <strong>pathogens</strong> are <strong>transmitted</strong> <strong>between individuals</strong>, and a <strong>high level</strong> of community immunity can <strong>prevent</strong> their spread, <strong>protecting </strong>even those who are <strong>not immunized</strong>.<strong>&nbsp;High vaccination rates</strong> in a population can provide <strong>herd immunity</strong>, <strong>reducing</strong> the likelihood of <strong>outbreaks</strong>.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd Immunity</strong> is the <strong>level of resistance</strong> of a community or group of people to a <strong>particular disease</strong>. It refers to <strong>group protection</strong> beyond what is <strong>afforded</strong> by the <strong>protection of immunized individuals</strong>. It helps to <strong>protect vulnerable people</strong> like <strong>babies</strong>, the <strong>elderly</strong> and to those who are <strong>immunocompromised.</strong>&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Elements</strong> contributing to <strong>herd immunity</strong> are the occurrence of <strong>clinical/subclinical</strong> <strong>infections in herd, immunization</strong> of the <strong>herd</strong>, and <strong>structure </strong>of the<strong> herd</strong> (hosts, alternative animal hosts, insect vectors, environmental &amp; social factors).</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is <strong>neither possible nor necessary</strong> to achieve <strong>100% herd immunity</strong> to <strong>control a disease</strong>.&nbsp;</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Herd immunity may be <strong>determined</strong> by <strong>Serological Surveys</strong>.&nbsp;</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd immunity</strong> describes a <strong>type of immunity</strong> that occurs when the <strong>vaccination</strong> of a portion of the <strong>population (or herd) protects un-vaccinated individuals</strong>.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd Immunity Threshold</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Virologists</strong> have found that when a <strong>certain percentage</strong> of a <strong>population</strong> is <strong>vaccinated</strong>, the <strong>spread</strong> of the <strong>disease</strong> is <strong>effectively stopped</strong>; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This critical percentage (HIT) depends on the disease and the vaccine:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-154429_HY7EM4y.jpg\" style=\"height:900px; width:1000px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Herd immunity</strong> is effective in <strong>controlling diseases</strong> spread from <strong>person to person</strong> like <strong>Diptheria, polio, measles</strong>, but it <strong>does not</strong> apply to disease such as <strong>tetanus</strong>, where <strong>infection</strong> occurs through <strong>environmental exposure</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 26<sup>th</sup> ed pg 111</strong></span></span></p>",
      "correct_choice_id": 25199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6317,
      "choices": [
        {
          "id": 25237,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1 day</span></span></p>"
        },
        {
          "id": 25238,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1 week</span></span></p>"
        },
        {
          "id": 25239,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3 weeks</span></span></p>"
        },
        {
          "id": 25240,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">4 weeks</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 14-week-old infant is brought to a Primary Health Center for routine immunizations. During this visit, she receives all her scheduled vaccines, but the Rota Virus Vaccine (RVV) is unavailable due to a shortage. As a result, she misses her third dose of RVV and is advised to return when it&#39;s available. For optimal immunization scheduling, it&#39;s important to know the minimum recommended interval between the administration of the RVV and other vaccines if they are not given on the same day. What is this minimum recommended interval before administering the RVV, following the administration of other vaccines?</span></span></p>",
      "unique_key": "Q3892438",
      "question_audio": null,
      "question_video": null,
      "map_id": 34085,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. 3 weeks</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When <strong>two live vaccines</strong> are required they should be given <strong>either simultaneously</strong> at <strong>different sites</strong> or with an <strong>interval </strong>of at least <strong>3 weeks.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">General <strong>rules</strong> for <strong>multiple vaccine administration</strong>:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>2 live vaccines</strong> can be given <strong>together&nbsp;</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Live and killed vaccines</strong> can be given <strong>together</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Live vaccine</strong> should <strong>not</strong> be administered to <strong>immuno-deficient or immunosuppressed</strong> persons</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>2 live vaccines</strong> can be administered simultaneously <strong>at different sites</strong> (or at an interval of 3 weeks)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Cholera vaccine and Yellow fever vaccine</strong> <strong>cannot</strong> be given <strong>together</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>OPV</strong> is the <strong>only&nbsp;live vaccine</strong> where a <strong>single dose</strong> is<strong> not sufficient</strong> for <strong>immunization</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Rules</strong> for <strong>Live Vaccine and Immunoglobulin</strong>:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Live vaccines</strong> should <strong>not</strong> normally be given for <strong>12 weeks</strong> <strong>after</strong> an injection of <strong>normal human Ig</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If a <strong>live vaccine</strong> has already been <strong>given,</strong> <strong>NHIg</strong> injection should be <strong>deferred</strong> for <strong>2 weeks</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Two live vaccines</strong> can be <strong>administered</strong> simultaneously <strong>at different sites</strong> (or at an <strong>interval</strong> of <strong>3 weeks</strong>)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>:&nbsp;Park 26<sup>th</sup> ed pg 111.&nbsp;</strong></span></span></p>",
      "correct_choice_id": 25239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6318,
      "choices": [
        {
          "id": 25241,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Detoxifies the micro organisms</span></span></p>"
        },
        {
          "id": 25242,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stabilizes the antigen</span></span></p>"
        },
        {
          "id": 25243,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Enhances the immune response</span></span></p>"
        },
        {
          "id": 25244,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Preservatives</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Community Medicine SR is conducting a session with medical students on vaccine formulations and their components. During the session, the topic shifts to the use of adjuvants in vaccines and their specific roles. The pediatrician highlights the Diphtheria, Tetanus, and Pertussis (DTaP) vaccine, pointing out that it contains aluminum phosphate. The students are then asked to consider why aluminum phosphate is included in this vaccine. What is the primary role of aluminum phosphate in the DTaP vaccine?</span></span></p>",
      "unique_key": "Q8702580",
      "question_audio": null,
      "question_video": null,
      "map_id": 34086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Enhances the immune response</strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Adjuvant</strong>&nbsp;are substance <strong>added</strong> to a <strong>vaccine</strong> to <strong>enhance</strong> the <strong>immune response</strong> by <strong>degree and/or duration</strong>, making it possible to <strong>reduce</strong> the amount of <strong>immunogen per dose</strong> or the <strong>total number of doses</strong> needed to <strong>achieve immunity</strong>. The <strong>commonly used</strong> adjuvant are <strong>Aluminium salts</strong> (aluminium hydroxide, aluminium phosphate or potassium aluminium sulfate) which primarily<strong> enhance</strong> the <strong>immune response</strong> to <strong>proteins.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Detoxifies the microorganisms</strong>:&nbsp;<strong>Preservatives</strong> are used to <strong>detoxify</strong> the <strong>microorganisms.</strong>&nbsp;<strong>Antibiotics</strong> are <strong>used </strong>during the manufacturing phase to <strong>prevent bacterial contamination</strong> of the <strong>tissue culture cells</strong> in which the <strong>viruses are grown</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B</strong>. <strong>Stabilizes the antigen:</strong>&nbsp;<strong>Stabilizers</strong> acts by controlling <strong>acidity (pH); stabilizing antigens</strong> through necessary steps in the manufacturing process, such as <strong>freeze drying</strong>; and <strong>preventing antigens</strong> from <strong>adhering</strong> to the sides&nbsp;of <strong>glass vials</strong> with a <strong>resultant loss</strong> in <strong>immunogenicity</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Examples - <strong>potassium or sodium salts, lactose, human serum albumin</strong> and a variety of animal proteins, such as <strong>gelatin</strong> and <strong>bovine serum albumin.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Preservatives:&nbsp;</strong>These&nbsp;are the chemicals (e.g.<strong> thiomersal, formaldehyde</strong>) added to <strong>killed or subunit vaccines</strong> in order to <strong>inactivate viruses</strong>, <strong>detoxify bacterial toxins</strong>, and to <strong>prevent</strong> serious <strong>secondary</strong> <strong>infections</strong> as a result of <strong>bacterial or fungal contamination.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>role of adjuvants</strong> like <strong>aluminum phosphate</strong> in vaccines, which is to <strong>enhance </strong>the <strong>immune response</strong> to the <strong>antigen</strong>, as seen in the <strong>Diphtheria vaccine.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 26<sup>th</sup> ed pg 114</strong></span></span></p>",
      "correct_choice_id": 25243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6320,
      "choices": [
        {
          "id": 25249,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">90% should be Ig G</span></span></p>"
        },
        {
          "id": 25250,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">All IgG subclass should be present</span></span></p>"
        },
        {
          "id": 25251,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Should contain high concentration of Ig A</span></span></p>"
        },
        {
          "id": 25252,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Should contain antibody against at least 2 bacterial and viral species</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a seminar on immunoglobulin therapy, a discussion arises about the World Health Organization (WHO) standards for Normal Human Immunoglobulin (NHIG) preparation. The speaker presents various criteria that define these standards and asks the audience to identify which of the given options is NOT included in the WHO standards for NHIG. This question aims to highlight a specific aspect of NHIG preparation that does not align with WHO guidelines.</span></span></p>",
      "unique_key": "Q2421753",
      "question_audio": null,
      "question_video": null,
      "map_id": 34087,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Should contain high concentration of IgA</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>NHIG</strong> is primarily focused on <strong>providing IgG</strong>; while it may <strong>contain</strong> <strong>some IgA</strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. 90% should be Ig G</strong>: Correct.&nbsp;This ensures the <strong>primary immunoglobulin</strong> in <strong>NHIG</strong> is <strong>IgG</strong>, known for its<strong> antibody</strong> <strong>activity against pathogens.</strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. All IgG subclass should be present</strong>: Correct.&nbsp;This is to maintain a <strong>broad spectrum of antibody activity</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Should contain antibody against atleast 2 bacterial and viral species</strong>: Correct.&nbsp;This criterion <strong>ensures</strong> the <strong>NHIG</strong> is <strong>effective against</strong> a <strong>range of pathogens.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>Normal Human Immunoglobulin</strong> preparation should <strong>contain:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">At least <strong>90 percent</strong> intact <strong>IgG</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It should be as <strong>free</strong> as possible from <strong>IgG aggregates</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">All <strong>IgG sub-classes</strong> should be <strong>present</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">There should be a <strong>low IgA concentration</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>level of</strong> <strong>antibody against</strong> at least <strong>two bacterial species</strong> and <strong>two viruses</strong> should be ascertained etc</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>WHO standards</strong> for <strong>Normal Human Immunoglobulin preparation</strong>, focus on the <strong>predominance</strong> of <strong>IgG (90%)</strong> and the presence of <strong>all IgG subclasses</strong>, and <strong>low concentration</strong> of <strong>IgA</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>:&nbsp;Park 26<sup>th</sup> ed pg 115</strong></span></span></p>",
      "correct_choice_id": 25251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6300,
      "choices": [
        {
          "id": 25169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Exposure to infections</span></span></p>"
        },
        {
          "id": 25170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inoculation of Immunoglobulins</span></span></p>"
        },
        {
          "id": 25171,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immunization with killed vaccine</span></span></p>"
        },
        {
          "id": 25172,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Exposure to subclinical infection</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical student is reviewing concepts of immunology. While discussing active immunity, the student is asked to identify which of the following methods does NOT confer active immunity. Which option should the student choose?</span></span></p>",
      "unique_key": "Q7397858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34088,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Inoculation of Immunoglobulins</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Immunoglobins render passive immunity.&nbsp;</strong><strong>Active immunity</strong> involves the body producing <strong>its own antibodies</strong> in response to an <strong>antigen</strong>. This can occur through <strong>natural processes</strong> like <strong>exposure</strong> to an <strong>infectious agent or </strong>through<strong> vaccination.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Active immunity may be acquired in 3 ways:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Exposure to infections:&nbsp;</strong>Following <strong>clinical</strong> infection, e.g., <strong>chickenpox, rubella, and measles.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Immunization with killed vaccine:</strong>&nbsp;Following <strong>immunization</strong> with an <strong>antigen</strong> which may be a<strong> killed vaccine, a live attenuated vaccine, or toxoid.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Exposure to subclinical infection:</strong>&nbsp;Following subclinical or<strong> inapparent</strong> infection, e.g., <strong>polio and diphtheria.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Active immunity</strong> may be <strong>acquired</strong> through&nbsp;<strong>clinical or subclinical infection or&nbsp;immunization,</strong> while<strong>&nbsp;Immunoglobins</strong> render <strong>passive immunity.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 26<sup>th</sup> ed pg 109.</strong></span></span></p>",
      "correct_choice_id": 25170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}